Low-dose, short-term treatment with anti-CD4 monoclonal antibody prolongs corneal allograft survival.
Thiel
M A
MA
Department of Ophthalmology, Flinders University of South Australia, Adelaide, Australia.
Takano
T
T
Hawksworth
N
N
Coster
D J
DJ
Williams
K A
KA
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015704:CD4 Antigens / Q000276:immunology*; D016039:Corneal Transplantation / Q000502:physiology*; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects*; D051381:Rats; D011916:Rats, Inbred F344; D011920:Rats, Inbred WF; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D015704:CD4 Antigens